Stocktoria
Neurogene Inc. NGNE
Neurogene Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $925,000 | $0 | — | — | — | — | $25.0M | — | — |
| R&D expense | $75.0M | $60.9M | $44.4M | $47.5M | $39.2M | — | — | $41.8M | $36.3M | $28.4M |
| Operating income | -$103.3M | -$82.6M | -$55.6M | -$56.5M | -$60.7M | -$33.7M | -$71.0M | -$32.6M | -$51.1M | -$37.6M |
| Interest expense | — | — | $12,000 | $2,000 | — | — | $1,000 | $4,000 | $4,000 | $1,000 |
| Income tax | $0 | $0 | — | — | — | — | — | — | — | $0 |
| Net income | -$90.4M | -$75.1M | -$36.3M | -$55.2M | -$60.7M | -$33.3M | -$69.4M | -$31.6M | -$50.2M | -$37.0M |
| EPS (diluted) | $-4.24 | $-4.28 | — | $-1.04 | $-1.10 | $-0.64 | — | — | — | — |
| Operating cash flow | -$77.2M | -$70.6M | -$51.4M | -$52.8M | -$47.6M | -$24.6M | -$15.4M | -$31.6M | -$44.7M | -$30.2M |
| Free cash flow | -$78.4M | -$71.4M | -$51.7M | -$55.1M | -$50.8M | -$26.8M | -$16.3M | -$31.6M | -$45.2M | -$30.9M |
| Cash & equivalents | $103.8M | $136.6M | $148.2M | $82.0M | $142.5M | $192.6M | $143.1M | $76.9M | $52.0M | $32.3M |
| Total assets | $288.6M | $335.7M | $222.6M | $109.3M | $163.3M | $210.5M | $147.0M | $77.6M | $110.3M | $154.4M |
| Total liabilities | $23.7M | $25.4M | $36.5M | $10.6M | $20.4M | $19.3M | $5.3M | $4.9M | $11.4M | $9.7M |
| Shareholders' equity | $264.9M | $310.4M | $186.0M | -$145.7M | -$91.9M | $191.2M | $141.7M | $72.7M | $98.9M | $144.7M |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -100.0% | — | — | — | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.